摘要:
The present invention relates to a process for the production of purified dimeric bone morphogenetic factors. Purified dimeric bone morphogenetic factor can be produced by subjecting an inclusion body of a bone morphogenetic factor produced by means of a genetic engineering technology to the following steps a) - e) in order;
a) treating an inclusion body of a bone morphogenetic factor with a denaturing agent to obtain a solubilized monomer, b) treating the solubilized monomer with a refolding solution to obtain a dimeric bone morphogenetic factor, c) treating the dimeric bone morphogenetic factor by ultrafiltration and substitution of solvent, d) subjecting the dimeric bone morphogenetic factor in solvent thus substituted to isoelectric precipitation, and e) subjecting the dimeric bone morphogenetic factor thus isoelectrically precipitated to reverse-phase chromatography.